What is the price of Wuhan Hiteck Biological Pharma Co.,Ltd (300683)

The price of Wuhan Hiteck Biological Pharma Co.,Ltd (300683) is $3.71

What is the market cap of Wuhan Hiteck Biological Pharma Co.,Ltd (300683)

The market cap of Wuhan Hiteck Biological Pharma Co.,Ltd (300683) is $486.16M

Wuhan Hiteck Biological Pharma Co.,Ltd (300683) Earnings

Wuhan Hiteck Biological Pharma Co.,Ltd is a biopharmaceutical enterprise operating in China, primarily engaged in the research, development, manufacturing, and commercialization of bio-engineered products and lyophilized injectable medications. The company's extensive product portfolio encompasses a variety of pharmaceutical solutions, such as Jinlujie, a mouse nerve growth factor for injection; omeprazole sodium for injection; cyclic adenosine phosphate; Xinye acyclovir tablets; Bingbing Horse & Dragon, an indomethacin furazolidone suppository; Xunkeyuan tinidazole suppository; and Shufu nimodipine sustained-release tablets. Beyond therapeutics, Wuhan Hiteck also provides a comprehensive array of diagnostic kits. These include tests for measles virus and rubella virus nucleic acid, mycoplasma isolation and identification, bacterial vaginosis rapid detection, measles virus IgG antibodies, and the coronavirus N-protein. Furthermore, the firm supplies active pharmaceutical ingredients (APIs) and their chemical intermediates, notably Lopinavir and Ritonavir. Its core therapeutic areas of focus are the nervous system and oncology. Established in 1992, Wuhan Hiteck Biological Pharma Co.,Ltd is headquartered in Wuhan, China.

Year	Earnings	Change
Not enough data for the provided dates.

Year

Earnings

Change

Not enough data for the provided dates.

Company	Earnings	Earnings Difference	Country
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$1.76B	-	IN
Galderma Group AG GALD.SW	-	-	CH

Company

Earnings

Earnings Difference

Country